- Published on 18 February 2014
Sales data released by the audiology division of the French National Association of Medical Technologies Industry (Snitem) indicate that the hearing aid sector showed a return to strong growth in 2013, with figures up 7.55%. While the market was characterized by a major slow-down in 2012 with growth of just 0.38%, 2013 marked a turn-around with a strong upswing in sales, similar to the growth seen in 2011 of 7.44%.
In total, 567,374 hearing aids were sold in 2013 compared to 527,772 in 2012, including those provided as part of France’s scheme for universal healthcare coverage (CMU).
The Snitem survey once again confirmed pole position for behind-the-ear (BTE) devices with an increase in sales of 3.18% against 2012 and a sales volume of 253,915 units. BTE battery 13 devices are still the top performer in this category with 186,469 units sold, up 1.3% versus 2012, accounting for some 33.3% of total sales for the year. BTE type 10s really took off in 2013 with the sale of 6,316 units compared to 3,352 in 2012, a jump of 88.4%.
Strong sales figures were also recorded for receiver-in-canal (RIC) devices, up 16.36% in 2013 with 249,332 units sold, compared to 214,272 in 2012. RIC 312 hearing aids still account for most sales at 38.2% of the total, and recorded a healthy increase of 25.52% with 213,687 units sold.
In-the-ear (ITE) models reached the figure of 56,013 units in 2013, a decrease of 5.09% with reference to 2012 sales of 59,019 units. Lastly, CMU device sales increased by 4.32% with 8,114 units sold versus 7,778 in 2012.
Companies that participated in the Snitem survey were: Audiomedi Hansaton, GN Hearing, Phonak, Prodition, Siemens, Starkey and Widex.